APLP1 anticorps (AA 39-300)
Aperçu rapide pour APLP1 anticorps (AA 39-300) (ABIN7144050)
Antigène
Voir toutes APLP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 39-300
-
Réactivité croisée
- Humain, Souris
-
Purification
- Antigen Affinity Purified
-
Immunogène
- Recombinant Human Amyloid-like protein 1 protein (39-300AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: WB:1:500-1:2000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- APLP1 (Amyloid beta (A4) Precursor-Like Protein 1 (APLP1))
-
Autre désignation
- APLP1
-
Sujet
-
Background: May play a role in postsynaptic function. The C-terminal gamma-secretase processed fragment, ALID1, activates transcription activation through APBB1 (Fe65) binding (By similarity). Couples to JIP signal transduction through C-terminal binding. May interact with cellular G-protein signaling pathways. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I.
Aliases: AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 1 antibody, AMYLOID PRECURSOR-LIKE PROTEIN antibody, Amyloid-like protein 1 precursor antibody, APLP 1 antibody, APLP antibody, APLP-1 antibody, Aplp1 antibody, APLP1_HUMAN antibody, C30 antibody
-
UniProt
- P51693
-
Pathways
- cAMP Metabolic Process
Antigène
-